FOXO TECHNOLOGIES INC. Operating Expenses
FOXO TECHNOLOGIES INC. (FOXO) reported Operating Expenses of -$4.03 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-14
- FOXO TECHNOLOGIES INC. operating expenses for the quarter ending 2026-06-30 was -$4.03M, a 186.72% decline year-over-year.
- FOXO TECHNOLOGIES INC. operating expenses for the quarter ending 2026-03-31 was $5.44M, a 15.43% increase year-over-year.
- FOXO TECHNOLOGIES INC. operating expenses for the quarter ending 2025-12-31 was $12.92M, a 89.76% increase year-over-year.
- FOXO TECHNOLOGIES INC. operating expenses for the quarter ending 2025-09-30 was $4.41M, a 100.20% increase year-over-year.
- FOXO TECHNOLOGIES INC. operating expenses for fiscal 2025 was $26.70M, a 125.99% increase from fiscal 2024.
- FOXO TECHNOLOGIES INC. operating expenses for fiscal 2024 was $11.81M, a 47.10% decline from fiscal 2023.
- FOXO TECHNOLOGIES INC. operating expenses for fiscal 2023 was $22.33M, a 44.63% decline from fiscal 2022.
- FOXO TECHNOLOGIES INC. operating expenses for fiscal 2022 was $40.33M, a 166.21% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.03M 10-Q · filed 2026-08-14 | $1.41M 10-Q · filed 2026-08-14 | $14.33M derived: sum of 3 quarters · filed 2026-08-14 | $18.74M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $5.44M 10-Q · filed 2026-05-15 | $18.37M derived: sum of 2 quarters · filed 2026-05-15 | $22.77M derived: sum of 3 quarters · filed 2026-05-15 | $27.42M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $12.92M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $17.33M derived: sum of 2 quarters · filed 2026-04-15 | $21.98M derived: sum of 3 quarters · filed 2026-08-14 | $26.70M 10-K · filed 2026-04-15 | ||||
| 2025-09-30 | $4.41M 10-Q · filed 2025-11-10 | $9.06M derived: sum of 2 quarters · filed 2026-08-14 | $13.78M 10-Q · filed 2025-11-10 | $20.59M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $4.65M 10-Q · filed 2026-08-14 | $9.37M 10-Q · filed 2026-08-14 | $16.18M derived: sum of 3 quarters · filed 2026-08-14 | $18.38M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $4.72M 10-Q · filed 2026-05-15 | $11.53M derived: sum of 2 quarters · filed 2026-05-15 | $13.73M derived: sum of 3 quarters · filed 2026-05-15 | $15.34M derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $6.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $9.01M derived: sum of 2 quarters · filed 2026-04-15 | $10.63M derived: sum of 3 quarters · filed 2026-04-15 | $11.81M 10-K · filed 2026-04-15 | ||||
| 2024-09-30 | $2.20M 10-Q · filed 2025-11-10 | $2.20M 10-Q · filed 2024-11-19 | $3.82M derived: sum of 2 quarters · filed 2025-11-10 | $5.00M 10-Q · filed 2025-11-10 | $5.00M 10-Q · filed 2024-11-19 | $8.87M derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2024-06-30 | $1.62M 10-Q · filed 2025-08-19 | $1.62M 10-Q · filed 2024-08-19 | $2.80M 10-Q · filed 2025-08-19 | $2.80M 10-Q · filed 2024-08-19 | $6.67M derived: sum of 3 quarters · filed 2025-08-19 | $10.11M derived: sum of 4 quarters · filed 2025-08-19 | ||
| 2024-03-31 | $1.19M 10-Q/A · filed 2025-08-19 | $1.19M 10-Q · filed 2024-06-28 | $5.05M derived: sum of 2 quarters · filed 2025-08-19 | $8.50M derived: sum of 3 quarters · filed 2025-08-19 | $16.11M derived: sum of 4 quarters · filed 2025-08-19 | |||
| 2023-12-31 | $3.86M derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $7.31M derived: sum of 2 quarters · filed 2025-04-15 | $14.93M derived: sum of 3 quarters · filed 2025-04-15 | $22.33M 10-K · filed 2025-04-15 | $22.20M 10-K · filed 2024-06-06 | |||
| 2023-09-30 | $3.45M 10-Q · filed 2024-11-19 | $11.06M derived: sum of 2 quarters · filed 2024-11-19 | $18.47M 10-Q · filed 2024-11-19 | $39.40M derived: sum of 4 quarters · filed 2024-11-19 | ||||
| 2023-06-30 | $7.62M 10-Q · filed 2024-08-19 | $15.02M 10-Q · filed 2024-08-19 | $35.96M derived: sum of 3 quarters · filed 2024-08-19 | $44.78M derived: sum of 4 quarters · filed 2024-08-19 | ||||
| 2023-03-31 | $7.41M 10-Q · filed 2024-06-28 | $28.34M derived: sum of 2 quarters · filed 2024-06-28 | $37.17M derived: sum of 3 quarters · filed 2024-06-28 | $43.14M derived: sum of 4 quarters · filed 2024-06-28 | ||||
| 2022-12-31 | $20.93M derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-06-06 | $29.76M derived: sum of 2 quarters · filed 2024-06-06 | $35.73M derived: sum of 3 quarters · filed 2024-06-06 | $40.33M 10-K · filed 2024-06-06 | ||||
| 2022-09-30 | $8.83M 10-Q/A · filed 2024-06-04 | $14.80M derived: sum of 2 quarters · filed 2024-06-04 | $19.40M 10-Q/A · filed 2024-06-04 | $22.59M derived: sum of 4 quarters · filed 2024-06-04 | ||||
| 2022-06-30 | $5.97M 10-Q · filed 2023-08-10 | $10.57M 10-Q · filed 2023-08-10 | $13.76M derived: sum of 3 quarters · filed 2023-08-10 | $18.15M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $4.60M 10-Q · filed 2023-05-11 | $7.79M derived: sum of 2 quarters · filed 2023-05-11 | $12.18M derived: sum of 3 quarters · filed 2023-05-11 | |||||
| 2021-12-31 | $3.19M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $7.58M derived: sum of 2 quarters · filed 2023-03-31 | $15.15M 10-K · filed 2023-03-31 | |||||
| 2021-09-30 | $4.39M 10-Q · filed 2022-11-21 | $11.96M 10-Q · filed 2022-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |